Skip to main content

Advertisement

Log in

β-Actin: An Emerging Biomarker in Ischemic Stroke

  • Review Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

At present, the diagnosis of ischemic stroke mainly depends on neuroimaging technology, but it still has many limitations. Therefore, it is very important to find new biomarkers of ischemic stroke. Recently, β-actin has attracted extensive attention as a biomarker of a variety of cancers. Although several recent studies have been investigating its role in ischemic stroke and other cerebrovascular diseases, the understanding of this emerging biomarker in neurology is still limited. We examined human and preclinical studies to gain a comprehensive understanding of the literature on the subject. Most relevant literatures focus on preclinical research, and pay more attention to the role of β-actin in the process of cerebral ischemia, but some recent literatures reported that in human studies, serum β-actin increased significantly in the early stage of acute cerebral ischemia. This review will investigate the basic biology of β-actin, pay attention to the potential role of serum β-actin as an early diagnostic blood biomarker of ischemic stroke, and explore its potential mechanism in ischemic stroke and new strategies for stroke treatment in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Abbreviations

ADF:

Actin depolymerization factor

AJ:

Adhesion junction

ATP:

Adenosine-triphosphate

BBB:

Blood brain barrier

DNA:

Deoxyribonucleic acid

DNase I:

Deoxyribonuclease

NMDA:

N-methyl-d-aspartic acid

OGD:

Oxygen and glucose deprivation

PD:

Parkinson disease

TJ:

Tight junction

References

Download references

Acknowledgements

Not applicable.

Funding

This work was funded by Medical Health Science and Technology Project of Zhejiang Provincial Health Commission and Planned Projects of Bureau of Science and Technology of Zhoushan, Grant Nos. 2022KY1367, 2018C11044.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization—SH, JL, FD, XK, BW and JX, writing—JL, funding acquisition—SH, resources—SH, JL, FD, XK, BW and JX, supervision—SH.

Corresponding author

Correspondence to Songbin He.

Ethics declarations

Confict of interest

The authors declare that they have no conflicts of interest.

Ethical Approval

Not applicable.

Consent for Publication

All authors consent to publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Dai, F., Kou, X. et al. β-Actin: An Emerging Biomarker in Ischemic Stroke. Cell Mol Neurobiol 43, 683–696 (2023). https://doi.org/10.1007/s10571-022-01225-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-022-01225-4

Keywords

Navigation